Literature DB >> 9800957

Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.

N Rubio1, M M Villacampa, J Blanco.   

Abstract

Tumor cell traffic between intramuscular tumors experimentally induced in nude mice and lymph nodes was studied using PC-3.luc prostate adenocarcinoma cells permanently transfected with the luciferase gene as a tumor cell marker. This sensitive approach allowed the detection of 1 luminescent tumor cell mixed with 1 x 10(7) unlabeled PC-3 cells and of 1 tumor cell/lymph node. PC-3.luc cells inoculated in nude mice showed a 1000-fold expansion, accompanied by a 4.5-fold increase in tumor cell density (tumor cell number/gram of tumor), during the first 90 days of primary tumor growth. No macroscopic secondary tumors were found in organs, other than lymph nodes, by the end of the experiment. Tumor cell spread to lymph nodes was detected at Day 21, when there were 2 x 10(5) tumor cells at the inoculation sites, before discrete primary tumors could be identified. The total tumor cell burden in the tested lymph nodes was modeled by a power function of primary tumor cell number (determination coefficient R2 = 0.9472). By the end of the experiment, on Day 110, there were 1.8 metastatic cells in the studied lymph nodes for every 1000 primary tumor cells. These results suggest that empirically obtained tumor-specific indexes could be used to characterize the invasion of lymph nodes by tumor cells. The path of spread for PC-3.luc cells from intramuscular sites appears to follow the lymphatic system, and at no time during the experiment were tumor cells found in blood. An upper limit of no more than 16 blood-circulating tumor cells was established for these experiments. The observation of tumor cells that were invading the lymphatic system from the onset of tumor growth but unable to establish secondary tumors in other organs emphasizes the potential of this procedure in studying the multi-step nature of metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800957

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

1.  Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Authors:  Julianne L Holleran; Carson J Miller; Nancy L Edgehouse; Theresa P Pretlow; Lloyd A Culp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.

Authors:  Lee Jia; Patricia E Noker; Gary A Piazza; Carola Leuschner; William Hansel; Gregory S Gorman; Lori U Coward; Joseph Tomaszewski
Journal:  J Pharm Pharmacol       Date:  2008-11       Impact factor: 3.765

3.  Glutaric acid as a spacer facilitates improved intracellular uptake of LHRH-SPION into human breast cancer cells.

Authors:  Challa S S R Kumar; Carola Leuschner; Michelle Urbina; Teyhida Ozkaya; Josef Hormes
Journal:  Int J Nanomedicine       Date:  2007

4.  Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation.

Authors:  Johanna Scheper; Marta Guerra-Rebollo; Glòria Sanclimens; Alejandra Moure; Isabel Masip; Domingo González-Ruiz; Nuria Rubio; Bernat Crosas; Oscar Meca-Cortés; Noureddine Loukili; Vanessa Plans; Antonio Morreale; Jerónimo Blanco; Angel R Ortiz; Angel Messeguer; Timothy M Thomson
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

5.  Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.

Authors:  Liat Izhak; Gizi Wildbaum; Steffen Jung; Avi Stein; Yuval Shaked; Nathan Karin
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.